BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14

• Press Releases

  Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights

  August 14, 2026

   · 

  9 min read
• Press Releases

  Maze Therapeutics Announces Appointments to Its Board of Directors

  August 14, 2026

   · 

  6 min read
• Press Releases

  Vogenx Announces Closing of Initial Public Offering

  August 14, 2026

   · 

  3 min read
• Press Releases

  NovaBridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026

  August 14, 2026

   · 

  1 min read
• Press Releases

  Satellos Reports Second Quarter 2026 Financial Results and Highlights Company Progress

  August 14, 2026

   · 

  12 min read
• Press Releases

  Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update

  August 14, 2026

   · 

  7 min read
• Press Releases

  Atrium Therapeutics Reports Second Quarter 2026 Financial Results

  August 14, 2026

   · 

  12 min read
• Press Releases

  Simulations Plus Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by Altaris

  August 14, 2026

   · 

  6 min read
• Press Releases

  U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb’s First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse

  August 14, 2026

   · 

  19 min read
• Press Releases

  BioSyent Schedules Q2 and H1 2026 Earnings Release for August 20, 2026

  August 14, 2026

   · 

  1 min read